TOP STORIES

• REGULATORY MHLW Revokes Approval for 12 Kobayashi Kako Products, Imposes Biz Improvement Order
  April 30, 2021

• BUSINESS Takeda, Eisai, Chemiphar Ran Early Retirement Programs over Past Year: Survey
  April 28, 2021

• BUSINESS Boehringer’s Japan Pharma Sales Rise 3.1% in 2020 on Ofev, Jardiance
  April 28, 2021

• BUSINESS Novartis Offering Voluntary Redundancy for 3rd Consecutive Year, Targets Sales & Medical across Therapeutic Areas
  April 27, 2021

• REGULATORY LDP Team Adopts Proposals to Push Japan-Made COVID-19 Vaccines, Urges Approval with Safety/Immunogenicity Studies
  April 27, 2021

• ACADEMIA New RA Guidelines Upgrade Position of JAK Inhibitors, Biosimilars on Equal Footing with Reference Products
  April 26, 2021

• REGULATORY Olumiant Snags Japan Approval for COVID-19
  April 23, 2021

• BUSINESS Chugai Eyes Japan Submission for COVID-19 Antibody Cocktail by Year-End
  April 23, 2021

• BUSINESS Supply Delays Likely for 160 Nichi-Iko Products despite Biz Suspension Lifted
  April 22, 2021

• REGULATORY Olumiant Now in Line for Japan Nod for COVID-19 Pneumonia
  April 22, 2021

• BUSINESS MSD Japan Suffers 7% Sales Dip on Repeated Keytruda Re-Pricing, Urges Policy Rethink
  April 21, 2021

• ORGANIZATION EFPIA Issues Proposals for Japanese CEA System, Says “Cannot Accept” Expansion without Corrective Steps
  April 21, 2021

• BUSINESS New Grad Hiring Down 3.3% at 55 Drug Makers, Sales Rep Opportunities Fall amid DX: Survey
  April 20, 2021

• REGULATORY MHLW to Revoke Approval of 12 Kobayashi Kako Products as Documents Fabricated
  April 19, 2021

• ORGANIZATION Scandals Making It Difficult to Recommend Generics to Members: Kyokai Kenpo Chair
  April 16, 2021

• REGULATORY Olumiant Up for PAFSC Review for COVID-19 on April 21, Combo Use with Veklury
  April 15, 2021

• BUSINESS Lilly Japan Set for Leading Spot in All Core Areas in 2025, “No Plan to Replicate” Redundancy Program: Chief
  April 14, 2021

• REGULATORY 11 APIs to Get NHI Price Listing on April 21, 17 Billion Yen Peak Sales Projected for Lilly’s Migraine Med
  April 14, 2021

• REGULATORY Kymriah to Face 4% Price Cut in 1st CEA-Based Price Tweak, Yescarta Too
  April 13, 2021

• BUSINESS Novo Japan Notches 10% Growth in 2020, President Proud of This Feat amid Market Decline
  April 13, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 90
• 91
• 92
• 93
• 94
• 95
• 96
• 97
• 98
• …
• Next ›
• 最終 »